$5.2 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 38 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 13.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FCEA | Sell | FOREST CITY RLTY TR INC | $543,754,000 | +7.9% | 21,672,157 | -1.9% | 10.46% | +18.9% |
| SPR | Buy | SPIRIT AEROSYSTEMS HLDGS INC | $491,453,000 | +13.3% | 5,361,113 | +6.1% | 9.46% | +24.7% |
| ITRI | Sell | ITRON INC | $346,691,000 | +5.3% | 5,400,168 | -1.5% | 6.67% | +15.9% |
| VST | Buy | VISTRA ENERGY CORP | $300,335,000 | +51.1% | 12,071,361 | +43.7% | 5.78% | +66.4% |
| HZNP | Buy | HORIZON PHARMA PLC | $289,047,000 | +46.5% | 14,762,354 | +23.9% | 5.56% | +61.4% |
| ZGNX | Buy | ZOGENIX INC | $263,203,000 | +69.8% | 5,306,514 | +51.3% | 5.07% | +86.9% |
| JCI | Sell | JOHNSON CTLS INTL PLC | $261,760,000 | +4.4% | 7,478,853 | -0.2% | 5.04% | +15.0% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $256,917,000 | -9.7% | 1,487,307 | -27.0% | 4.94% | -0.5% |
| ARRS | Buy | ARRIS INTL INC | $233,910,000 | +133.0% | 9,000,000 | +119.1% | 4.50% | +156.5% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $211,092,000 | -44.1% | 726,100 | -47.8% | 4.06% | -38.4% |
| RTRX | RETROPHIN INC | $187,303,000 | +5.4% | 6,519,425 | 0.0% | 3.60% | +16.1% | |
| JD | Buy | JD COM INCspon adr cl a | $186,385,000 | -5.2% | 7,143,928 | +41.5% | 3.59% | +4.4% |
| ISBC | Buy | INVESTORS BANCORP INC NEW | $174,112,000 | +23.5% | 14,190,051 | +28.8% | 3.35% | +36.1% |
| SRC | Sell | SPIRIT RLTY CAP INC NEW | $150,670,000 | -22.8% | 18,693,585 | -23.1% | 2.90% | -15.0% |
| ACOR | Sell | ACORDA THERAPEUTICS INC | $139,652,000 | -36.3% | 7,106,955 | -6.9% | 2.69% | -29.8% |
| MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $138,477,000 | -3.3% | 4,724,581 | -38.4% | 2.66% | +6.5% |
| W | Sell | WAYFAIR INCcl a | $131,810,000 | -47.7% | 892,600 | -57.9% | 2.54% | -42.4% |
| EQT | Buy | EQT CORP | $104,986,000 | +2.2% | 2,373,631 | +27.4% | 2.02% | +12.5% |
| CNMD | Sell | CONMED CORP | $95,448,000 | -24.4% | 1,204,851 | -30.1% | 1.84% | -16.7% |
| IWM | Sell | ISHARES TRput | $85,320,000 | -79.9% | 506,200 | -80.5% | 1.64% | -77.9% |
| WFTIQ | Buy | WEATHERFORD INTL PLC | $84,064,000 | -4.2% | 31,019,881 | +16.3% | 1.62% | +5.5% |
| PTCT | Sell | PTC THERAPEUTICS INC | $75,999,000 | -2.2% | 1,616,998 | -29.8% | 1.46% | +7.7% |
| ETM | Sell | ENTERCOM COMMUNICATIONS CORPcl a | $62,810,000 | -19.4% | 7,950,651 | -23.0% | 1.21% | -11.2% |
| THC | Buy | TENET HEALTHCARE CORP | $52,830,000 | -15.2% | 1,856,285 | +0.0% | 1.02% | -6.6% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $52,141,000 | -30.8% | 2,590,212 | +0.3% | 1.00% | -23.8% |
| PRTA | Buy | PROTHENA CORP PLC | $51,227,000 | +0.1% | 3,916,407 | +11.6% | 0.99% | +10.2% |
| New | RETROPHIN INCnote 2.500% 9/1 | $49,411,000 | – | 48,000,000 | +100.0% | 0.95% | – | |
| YMAB | New | Y MABS THERAPEUTICS INC | $42,166,000 | – | 1,587,566 | +100.0% | 0.81% | – |
| AYI | ACUITY BRANDS INC | $29,228,000 | +35.7% | 185,930 | 0.0% | 0.56% | +49.3% | |
| SMTA | Sell | SPIRIT MTA REIT | $27,765,000 | +11.7% | 2,410,153 | -0.1% | 0.53% | +23.0% |
| PAGP | Sell | PLAINS GP HLDGS L Pltd partnr int a | $25,879,000 | -71.6% | 1,055,000 | -72.4% | 0.50% | -68.8% |
| CVON | Sell | CONVERGEONE HLDGS INC | $14,448,000 | -24.0% | 1,551,828 | -23.3% | 0.28% | -16.3% |
| FOSL | FOSSIL GROUP INC | $9,217,000 | -13.4% | 395,925 | 0.0% | 0.18% | -4.8% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $8,208,000 | +50.6% | 64,961 | 0.0% | 0.16% | +66.3% | |
| SAFM | SANDERSON FARMS INC | $7,948,000 | -1.7% | 76,887 | 0.0% | 0.15% | +8.5% | |
| IFRX | New | INFLARX NV | $7,038,000 | – | 205,080 | +100.0% | 0.14% | – |
| MNKD | MANNKIND CORP | $3,050,000 | -3.7% | 1,666,498 | 0.0% | 0.06% | +7.3% | |
| AMSC | AMERICAN SUPERCONDUCTOR CORP | $136,000 | -0.7% | 19,610 | 0.0% | 0.00% | +50.0% | |
| BIDU | Exit | BAIDU INCspon adr rep a | $0 | – | -507,893 | -100.0% | -2.16% | – |
| ATUS | Exit | ALTICE USA INCcl a | $0 | – | -10,074,693 | -100.0% | -3.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
| ISHARES TR | 28 | Q3 2023 | 10.9% |
| MANNKIND CORP | 24 | Q3 2023 | 0.5% |
| BAIDU INC | 21 | Q2 2018 | 8.6% |
| ITRON INC | 21 | Q3 2020 | 12.1% |
| RETROPHIN INC | 20 | Q3 2020 | 4.5% |
| HARMONIC INC | 19 | Q3 2023 | 10.5% |
| JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
| ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
| Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
| Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
| Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
| ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
| ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
| ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
| Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
| GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D | 2024-04-26 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2024-01-22 |
| 13F-HR/A | 2023-11-14 |
| 13F-HR | 2023-11-14 |
| SC 13D | 2023-09-21 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.